Identification of five mouse μ-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon

Gene

Volumn 395, Issue 1-2, 2007, Pages 98-107

  Doyle, Glenn A ^a   Sheng, X Rebecca ^a   Lin, Sharon S J ^a   Press, Danielle M ^a   Grice, Dorothy E ^a   Buono, Russell J ^a   Ferraro, Thomas N ^a   Berrettini, Wade H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

C57BL 6; cDNA; DBA 2; Murine; Opiate receptor

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MU OPIATE RECEPTOR; PROTEIN OPRM1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; EXON; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE LOCATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

3' UNTRANSLATED REGIONS; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BRAIN; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; EXONS; INTRONS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; PROTEIN BIOSYNTHESIS; RECEPTORS, OPIOID, MU; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; VARIATION (GENETICS);

MURINAE; RATTUS;

EID: 34247608648     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2007.02.004     Document Type: Article

References (44)

1. Abbadie C., and Pasternak G.W. Differential in vivo internalization of MOR-1 and MOR-1C by morphine. NeuroReport 12 14 (2001) 3069-3072
2. Abbadie C., Pan Y.-X., Drake C.T., and Pasternak G.W. Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS. Neuroscience 100 1 (2000) 141-153
3. Altschul S.F., Gish W., Miller W., Myers E.W., and Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215 3 (1990) 403-410
4. Blom N., Gammeltoft S., and Brunak S. Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294 5 (1999) 1351-1362
5. Chowdhury B., et al. Decreased stability and translation of T cell receptor zeta mRNA with an alternatively spliced 3′-untranslated region contribute to zeta chain down-regulation in patients with systemic lupus erythematosus. J. Biol. Chem. 280 19 (2005) 18959-18966 [Electronic publication 2005 Mar 2]
6. Cokol M., Nair R., and Rost B. Finding nuclear localization signals. EMBO Rep. 1 5 (2000) 411-415
7. Doyle G.A., Sheng X.R., Lin S.S.J., Press D.M., Grice D.E., Buono R.J., Ferraro T.N., and Berrettini W.H. Identification of three mouse μ-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon. Gene 388 1-2 (2007) 135-147 [Electronic publication 2006 November 1]
8. Evans C.J. Agonist selective mu-opioid receptor trafficking in rat central nervous system. Mol. Psychiatry 5 2 (2000) 121
9. Ferguson S.S.G. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53 1 (2001) 1-24
10. Giros B., Pohl M., Rochelle J.M., and Seldin M.F. Chromosomal localization of opioid peptide and receptor genes in the mouse. Life Sci. 56 18 (1995) PL369-PL375
11. Guang W., Wang H., Su T., Weinstein B., and Wang J.B. Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia. Mol. Pharmacol. 66 (2004) 1285-1292
12. Hesketh J. 3′-Untranslated regions are important in mRNA localization and translation: lessons from selenium and metallothionein. Biochem. Soc. Trans. 32 6 (2004) 990-993
13. Huang H.D., Lee T.Y., Tzeng S.W., and Horng J.T. KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites. Nucleic Acids Res. 33 (2005) W226-W229 Jul 1(Web Server issue)
14. Hughes T.A. Regulation of gene expression by alternative untranslated regions. Trends Genet. 22 3 (2006) 119-122 [Electronic publication 2006 Jan 23]
15. Huttelmaier S., et al. Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1. Nature 438 7067 (2005) 512-515
16. Kaufman D.L., et al. Characterization of the murine μ opioid receptor gene. J. Biol. Chem. 270 26 (1995) 15877-15883
17. Keith D.E., et al. Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271 32 (1996) 19021-19024
18. Keith D.E., et al. mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol. Pharmacol. 53 3 (1998) 377-384
19. Kent W.J. BLAT - the BLAST-like alignment tool. Genome Res. 12 4 (2002) 656-664
20. Koch T., et al. C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization. J. Biol. Chem. 276 33 (2001) 31408-314014
21. Koch T., Schulz S., Schröder H., Wolf R., Raulf E., and Höllt V. Carboxy-terminal splicing of the rat μ opioid recptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem. 273 22 (1998) 13652-13657
22. Kozak C.A., Filie J., Adamson M.C., Chen Y., and Yu L. Murine chromosomal location of the μ and κ opioid receptor genes. Genomics 21 3 (1994) 659-661
23. Kvam T.-M., Baar C., Rakvag T.T., Kaasa S., Krokan H.E., and Skorpen F. Genetic analysis of the murine μ opioid receptor: increased complexity of Oprm1 gene splicing. J. Mol. Med. 82 4 (2004) 250-255
24. Lee D.K., et al. Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J. Biol. Chem. 279 9 (2004) 7901-7908 [Electronic publication 2003 Nov 26]
25. Liang Y., Mestek A., Yu L., and Carr L.G. Cloning and characterization of the promoter region of the mouse mu opioid receptor gene. Brain Res. 679 1 (1995) 82-88
26. Lu D., Yang H., Shaw G., and Raizada M.K. Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1) receptor in brain neurons. Endocrinology 139 1 (1998) 365-375
27. Min B.H., Augustin L.B., Felsheim R.F., Fuchs J.A., and Loh H.H. Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. Proc. Natl. Acad. Sci. U. S. A. 91 19 (1994) 9081-9085
28. Onoprishvili I., Andria M.L., Kramer H.K., Ancevska-Taneva N., Hiller J.M., and Simon E.J. Interaction between the mu opioid receptor and filamin A is involved in receptor regulation and trafficking. Mol. Pharmacol. 64 (2003) 1092-1100
29. Pak Y., O'Dowd B.F., and George S.R. Agonist-induced desensitization of the μ opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal Tail. J. Biol. Chem. 272 40 (1997) 24961-24965
30. Pan Y.X. Identification and characterization of a novel promoter of the mouse mu opioid receptor gene (Oprm1) that generates eight splice variants. Gene 295 1 (2002) 97-108
31. Pan Y.X. Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol. 24 11 (2005) 736-750
32. Pan Y.X., et al. Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms. Mol. Pharmacol. 56 2 (1999) 396-403
33. Pan Y.X., et al. Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F. FEBS Lett. 466 2-3 (2000) 337-340
34. Pan Y.X., Xu J., Mahurter L., Bolan E., Xu M., and Pasternak G.W. Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm1 gene. Proc. Natl. Acad Sci. U. S. A. 98 24 (2001) 14084-14089
35. Pan Y.X., Xu J., Bolan E., Moskowitz H.S., Xu M., and Pasternak G.W. Identification of four novel MOR-1B splice variants of the mouse mu opioid receptor gene: functional consequences of C-terminus splicing. Mol. Pharmacol. 68 3 (2005) 866-875
36. Pasternak G.W. The pharmacology of mu analgesics: from patients to genes. Neuroscientist 7 3 (2001) 220-231
37. Ross J. mRNA stability in mammalian cells. Microbiol. Rev. 59 3 (1995) 423-450
38. Smit, A.F.A., Hubley, R., Green, P. unpublished data. Current Version: open-3.1.
39. Sternini C., et al. Agonist-selective endocytosis of μ opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. U. S. A. 93 17 (1996) 9241-9246
40. Thiele A., Nagamine Y., Hauschildt S., and Clevers H. AU-rich elements and alternative splicing in the β-catenin 3′ UTR can influence the human β-catenin mRNA stability. Exp. Cell Res. 312 12 (2006) 2367-2378 [Electronic publication 2006 Apr 15]
41. Wolf R., et al. Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat μ opioid receptor. Mol. Pharmacol. 55 2 (1999) 263-268
42. Wood P.L., and Iyengar S. Central actions of opiates and opioid peptides: in vivo evidence for opioid receptor multiplicity. In: Pasternak G.W. (Ed). The Opiate Receptors (1988), Humana Press Inc., Clifton, N.J. 307-356
43. Zaki P.A., Keith Jr. D.E., Brine G.A., Carroll F.I., and Evans C.J. Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?. J. Pharmacol. Exp. Ther. 292 3 (2000) 1127-1134
44. Zimprich A., Simon T., and Höllt V. Cloning and expression of an isoform of the rat μ opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1. FEBS Lett. 359 2-3 (1995) 142-146